Analytical and assay issues for use of cardiac troponin testing for risk stratification in primary care

Clinical Biochemistry

Volumn 46, Issue 12, 2013, Pages 969-978

  Wu, Alan H B ^a   Christenson, Robert H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Biological variation; Cardiac troponin; Primary cardiovascular disease risk; Reversible injury; Standardization

Indexed keywords

TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANAEROBIC METABOLISM; ANGIOCARDIOGRAPHY; CARDIOLOGIST; CARDIOVASCULAR RISK; CELL MEMBRANE; CLINICAL PRACTICE; DYSPNEA; EMERGENCY PHYSICIAN; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HISTOLOGY; HUMAN; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEPTIC SHOCK; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STANDARDIZATION; STRESS ECHOCARDIOGRAPHY; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

ACC; ACUTE MYOCARDIAL INFARCTION; AHA; AMERICAN COLLEGE OF CARDIOLOGY; AMERICAN HEART ASSOCIATION; AMI; BIOLOGICAL VARIATION; CARDIAC TROPONIN; CARDIAC TROPONIN I AND T; CK; COEFFICIENT OF VARIANCE ANALYTICAL, INTRAINDIVIDUAL, AND INTERINDIVIDUAL; CREATINE KINASE; CTNI AND CTNT; CV(A), CV(I), CV(G); ESC; EUROPEAN SOCIETY OF CARDIOLOGY; IFCC; II; INDEX OF INDIVIDUALITY; INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY; INTERNATIONAL ORGANIZATION FOR STANDARDIZATION; INTERNATIONAL SYSTEM OF UNITS; ISO; NACB; NATIONAL ACADEMY OF CLINICAL BIOCHEMISTRY; PRIMARY CARDIOVASCULAR DISEASE RISK; RCV; RECEIVER OPERATING CHARACTERISTIC; REFERENCE CHANGE VALUE; REFERENCE MATERIAL; REVERSIBLE INJURY; RM; ROC; SI; SMCD; SRM; STANDARD REFERENCE MATERIAL; STANDARDIZATION; STANDARDIZATION OF MARKERS OF CARDIAC DAMAGE; WHO; WORLD HEALTH ORGANIZATION;

CHEMISTRY TECHNIQUES, ANALYTICAL; HUMANS; IMMUNOASSAY; MYOCARDIUM; PRIMARY HEALTH CARE; RISK ASSESSMENT; TROPONIN;

EID: 84880620939     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.04.013     Document Type: Review

References (78)

1. Nomenclature and criteria for diagnosis of ischemic heart disease. World Health Organization Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979, 50:607-609.
2. Cummins B., Auckland M.L., Cummins P. Cardiac-specific troponin radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987, 113:1333-1344.
3. Katus H.A., Remppis A., Looser S., Hallermeier K., Scheffold T., Kubler W. Enzyme linked immune assay of acute myocardial infarction in patients. J Mol Cell Cardiol 1989, 21:1349-1353.
4. Wu A.H.B., Apple F.S., Gibler W.B., Jesse R.L., Warshaw M.M., Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for use of cardiac markers in coronary artery diseases. Clin Chem 1999, 45:1104-1121.
5. Myocardial infarction redefined. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000, 21:1502-1513.
6. Thygesen K., Alpert J.S., White H.D., Jaffe A.S., Apple F.S., Galvani M., et al. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
7. Jaffe A.S., Apple F.S., Morrow D.A., Lindahl B., Katus H.A. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem 2010, 56:941-943.
8. Apple F.S., Parvin C.A., Buechler K.F., Christenson R.H., Wu A.H.B. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem 2005, 51:2198-2200.
9. Wu A.H.B. Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression. Intensive Care Med 2001, 27:959-960. [Editorial].
10. Melanson S.E.F., Morrow D.A., Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007, 128:282-286.
11. Hamm C.W., Ravkilde J., Gerhardt W., Jorgensen P., Peheim E., Ljundahl L., et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992, 327:146-150.
12. Wu A.H.B., Ford L. Release of biochemical markers in acute coronary syndromes: ischemia or only necrosis?. Clin Chim Acta 1999, 284:161-171.
13. Feng Y.J., Chen C., Fallon J.T., Ma L., Waters D.D., Wu A.H.B. Comparison of cardiac troponin I, creatine kinase-MB, and myoglobin for detection of acute myocardial necrosis in a swine myocardial ischemic model. Am J Clin Pathol 1998, 110:70-77.
14. Ammann P., Fehr T., Minder E.I., Gunter C., Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001, 27:965-969.
15. Sabatine M.S., Morrow D.A., de Lemos J.A., Jarolim P., Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009, 30:162-169.
16. Turer A.T., Addo T.A., Martin J.L., Sabatine M.S., Lewis G.D., Gerszten R.E., et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay. J Am Coll Cardiol 2011, 57:2398-2405.
17. White H.D. Pathobiology of troponin elevations. Do elevations occur with myocardial ischemia as well as necrosis?. J Am Coll Cardiol 2011, 57:2406-2408.
18. Hickman P.E., Potter J.M., Aroney C., Koerbin G., Southcott E., Wu A.H.B., et al. Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta 2010, 411:318-323.
19. Schwartz P., Piper H.M., Spahr R., Spieckermann P.G. Ultrastructure of cultured adult myocardial cells during anoxia and reoxygenation. Am J Pathol 1984, 115:349-361.
20. Frankenstein L., Wu A.H.B., Hallermayer K., Wians F.H., Giannitsis E., Katus H.A. Biological variation and reference change value of high sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem 2011, 57:1068-1071.
21. Wu A.H.B., Akhigbe P., Wians F. Long-term biological variation in cardiac troponin I. Clin Biochem 2012, 45:714-716.
22. Vasile V.C., Saenger A.K., Kroning J.M., Klee G.G., Jaffe A.S. Biological variation of a novel cardiac troponin I assay. Clin Chem 2011, 57:1080-1081.
23. Nordenskjold A.M., Ahlstrom H., Eggers K.M., Frobert O., Jaffe A.S., Venge P., et al. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem 2013, 59:401-409.
24. Fraser C.G. Biological variation: from principles to practice 2001, 106. AACC Press, Washington DC.
25. Wu A.H.B., Lu A., Todd J., Moecks J., Wians F. Short- and long-term biological variation in cardiac troponin I with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009, 55:52-58.
26. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002, 347:161-167.
27. Januzzi J.L., Camargo C.A., Anwaruddin S., Baggish A.L., Chen A.A., Krauser D.G., et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005, 95:948-954.
28. Reichlin T., Schindler C., Drexler B., Twerenbold R., Reiter M., Zellweger C., et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012, 172:1211-1218.
29. Wu A.H.B. Analytical issues for the clinical use of cardiac troponin. Cardiovascular Biomarkers: Pathophysiology and Disease Management 2006, 27-40. Humana Press, Totowa, NJ, [pgs. 620, EISBN159745_051_0]. D.M. Morrow (Ed.).
30. Gaze D.C., Collinson P.O. Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance. Ann Clin Biochem 2008, 45:349-355.
31. Labugger R., Organ L., Collier C., Atar D., Van Eyk J.E. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 2000, 102:1221-1226.
32. Cobbaert C.M., Weykamp C.W., Michielsen E.C.H.J., Baadenhuijsen H., van Dieijen-Visser M.P. Time-dependent instability of cardiac troponins in human plasma spiked with NIST reference material 2921. Clin Chem 2008, 54:2078-2079.
33. Panteghini M., Gerhardt W., Apple F.S., Dati F., Ravkilde J., Wu A.H. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001, 39:175-179.
34. Noble J.E., Bunk D.M., Christenson R.H., Cole K.D., He H.-J., Katrukha A.G., et al. Development of a candidate secondary reference procedure (immunoassay based measurement procedure of higher metrological order) for cardiac troponin I: I. Antibody characterization and preliminary validation. Clin Chem Lab Med 2010, 48:1603-1610.
35. Panteghini M., Bunk D.M., Christenson R.H., Katrukha A., Porter R.A., Schimmel H., et al. Standardization of troponin I measurements: an update. Clin Chem Lab Med 2008, 46(11):1501-1506.
36. Eriksson S., Junikka M., Laitinen P., Majamaa-Voltti K., Alfthan H., Pettersson K. Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component. Clin Chem 2003, 49:1095-1104.
37. Eriksson S., Hellman J., Pettersson K. Autoantibodies against cardiac troponins. N Engl J Med 2005, 352:98-100.
38. Eriksson S., Halenius H., Pulkki K., Hellman J., Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem 2005, 51:839-847.
39. Pettersson K., Eriksson S., Wittfooth S., Engström E., Nieminen M., Sinisalo J. Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients. Clin Chem 2009, 55:938-945.
40. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D. Third universal definition of myocardial infarction. Circulation 2012, 126:2020-2035.
41. Morrow D.A., Cannon C.P., Jesse R.L., Newby L.K., Ravkilde J., Storrow A.B., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007, 115:e356-e375.
42. Bunk D.M. Reference materials and reference measurement procedures: an overview from a national metrology institute. Clin Biochem Rev 2007, 28(4):131-137.
43. deFilippi C.R., de Lemos J.A., Christenson R.H., Gottdiener J.S., Kop W.J., Zhan M., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304:2494-2502.
44. Kociol R.D., Pang P.S., Gheorghiade M., Fonarow G.C., O'Connor C.M., Felker G.M. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010, 56:1071-1078.
45. Christenson R.H., Duh S.H., Apple F.S., Bodor G.S., Bunk D.M., Dalluge J., et al. Standardization of cardiac troponin I assays: round Robin of ten candidate reference materials. Clin Chem 2001, 47:431-437.
46. Christenson R.H., Duh S.H., Apple F.S., Bodor G.S., Bunk D.M., Panteghini M., et al. Toward standardization of cardiac troponin I measurements part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays. Clin Chem 2006, 52:1685-1692.
47. Tate J.R., Bunk D.M., Christenson R.H., Katrukha A., Noble J.E., Porter R.A., et al. Standardisation of cardiac troponin I measurement: past and present. Pathology 2010, 42:402-408.
48. Clinical and Laboratory Standards Institute Protocols for Determination of Limits of Detection and Limits of Quantitation, Approved Guideline 2004, CLSI, Wayne, PA USA, [CLSI document EP17].
49. Miller W.G., Myers G.L., Gantzer M., Kahn S.E., Schönbrunner E.R., Thienpont L.M., et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011, 57:1108-1117.
50. Bunk D.M., Welch M.J. Characterization of a new certified reference material for human cardiac troponin I. Clin Chem 2006, 52:212-219.
51. Sacks D.B. National Academy of Clinical Biochemistry: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus Available from:. http://www.aacc.org/members/nacb/LMPG/OnlineGuide/PublishedGuidelines/diabetes_update/Documents/DiabetesEntireLMPG.pdf.
52. Jeppsson J.-O., Kobold U., Barr J., Finke A., Hoelzel W., Hoshino T., et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002, 40:78-89.
53. Kallner A. International standards in laboratory medicine. Clin Chim Acta 2001, 307:181-186.
54. International Organization for Standardization In vitro diagnostic medical devices. Measurement of Quantities in Biological Samples: Metrological Traceability of Values Assigned to Calibrators and Control Materials 2003, ISO 17511, International ISO, Geneva, [Available from: http://www.google.com/xhtm].
55. Wu A.H.B., Valdes R., Apple F.S., Gornet T., Stone M.A., Mayfield-Stokes S., et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994, 40:900-907.
56. Wu A.H.B., Feng Y.J., Contois J.H., Pervaiz S. Comparison of myoglobin, creatine kinase MB, and cardiac troponin I for the diagnosis of acute myocardial infarction. Ann Clin Lab Sci 1996, 26:291-300.
57. Thygesen K., Alpert J.S., As Jaffe, Simoons M.L., Chaitman B.R., White H.D. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012, 60:1581-1598.
58. Thygesen K., Mair J., Giannitsis E., Mueller C., Lindahl B., Blankenberg S., et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012, 33:2252-2257.
59. Christenson R.H., Duh S.H. Methodological and analytic considerations for blood biomarkers. Prog Cardiovasc Dis 2012, 55:25-33.
60. Analytical characteristics of commercial troponin I and T assays declared by the manufacturer http://www.ifcc.org/media/102199/IFCC_Troponin_Table_vDec_2010_FINAL_ng_L_28Jan11.pdf.
61. Apple F.S. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2010, 57:1303-1306.
62. Keller T., Munzel T., Blankenberg S. Making it more sensitive. The new era of troponin use. Circulation 2011, 123:1361-1363.
63. Horowitz G.L., Altaie S., Boyd J.C., Eriotti F., Garg U., Horn P., et al. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline-3rd ed. Clin Lab Stand Inst 2008, 28(30). [C28-A3].
64. Apple F.S., Ler R., Murakami M.A. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012, 58:1574-1581.
65. Venge P., Johnston N., Lindahl B., James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial infarction. J Am Coll Cardiol 2009, 54:1165-1172.
66. Kavsak P.A., Allen L.C., Apple F.S., Booth R.A., Chan P.K., Delvin E., et al. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays-an update from the Canadian society of clinical chemists (CSCC). Clin Biochem 2011, 44:1273-1277.
67. Vasikaran S.D., Bima A., Botros M., Sikaris K. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays-an update from the Canadian society of clinical chemists (CSCC); the case for age related acute myocardial infarction (AMI) cut-offs. Clin Biochem 2012, 45:513-514.
68. Collinson P.O., Heung Y.M., Gaze D., Boa F., Senior R., Christenson R., et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012, 58:219-225.
69. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final report. Circulation 2002, 106:3142-3421.
70. Myers G.L., Christenson R.H., Cushman M., Ballantyne C.M., Cooper G.R., Pfeiffer C.M., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: emerging biomarkers for primary prevention of cardiovascular disease 2009, AACC Press, Washington DC.
71. Zannad F., De Backer G., Graham I., Lorenz M., Mancia G., Morrow D.A., et al. for the ESC Working Group on CardioVascular Pharmacology and Drug Therapy. Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques. Fundam Clin Pharmacol 2012, 26:163-174.
72. Kessler T., Schunkert H. Clinical validation of genetic markers for improved risk estimation. Eur J Prev Cardiol 2012, 19:25-32.
73. Choudhury R.P., Fisher E.A. Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation. Arterioscler Thromb Vasc Biol 2009, 29:983-991.
74. De Lemos J.A., Drazner M.H., Omland T., Ayers C.R., Khera A., Rohatgi A., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304:2503-2512.
75. Wang T.J., Wollert K.C., Larson M.G., Coglianese E., McCabe E.L., Cheng S., et al. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012, 126:1596-1604.
76. Apple F.S., Steffen L.M., Pearce L.A., Murakami M.M., Luepker R.B. Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey. Clin Chem 2012, 58:930-935.
77. deFilippi C.R., de Lemos J.A., Tkaczuk A.T., Christenson R.H., Cartnethon M.R., Siscovick D.S., et al. Physical activity, changes in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults. J Am Coll Cardiol 2012, 60:2539-2547.
78. O'Malley R., Morrow D., Cannon C., Bonaca M., Murphy S., Jarolim P., et al. Determination of high-sensitivity troponin in stable ischemic heart disease: analysis from PROVE IT-TIMI-22. Circulation 2012, Lippincott Williams and Wilkins, Los Angeles, CA, [126Suppl:A11559, Abstract].